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OBJECTIVE — Insulin resistance and -cell dysfunction both are important contributors to
the pathogenesis of type 2 diabetes. Exercise training improves insulin sensitivity, but its effects
on -cell function are less well studied.
RESEARCH DESIGN AND METHODS — Sedentary, overweight adults were random-
izedtocontroloroneofthree8-monthexerciseprograms:1)lowamount/moderateintensity,2)
low amount/vigorous intensity, or 3) high amount/vigorous intensity. Of 387 randomized, 260
completed the study and 237 had complete data. Insulin sensitivity (Si), acute insulin response
toglucose(AIRg),andthedispositionindex(DISiAIRg)weremodeledfromanintravenous
glucose tolerance test.
RESULTS — Compared with control subjects, all three training programs led to increases in
DI.However,themoderate-intensitygroupexperiencedasigniﬁcantlylargerincreaseinDIthan
either of the vigorous-intensity groups and through a different mechanism. The high-amount/
vigorous-intensity group improved Si and had a compensatory reduction in AIRg, whereas the
moderate-intensity group had a similar improvement in Si but almost no reduction in AIRg.
Importantly, the inactive control group experienced a signiﬁcant increase in fasting glucose.
CONCLUSIONS — TotheextentthattheDIaccuratelyreﬂects-cellfunction,weobserved
that both moderate- and vigorous-intensity exercise training improved -cell function, albeit
through distinct mechanisms. It is not clear which of these mechanisms is preferable for main-
tenance of metabolic health. While moderate-intensity exercise led to a larger improvement in
DI,whichmayreﬂectatransitiontowardamorenormalDI,longer-terminvestigationswouldbe
necessary to determine which was more effective at reducing diabetes risk.
Diabetes Care 32:1807–1811, 2009
I
nsulin resistance and pancreatic -cell
dysfunction are important contribu-
tors to the pathogenesis of type 2 dia-
betes (1–3). Sedentary, overweight, and
obese individuals are generally insulin
resistant but often are able to maintain
normal glucose tolerance through com-
pensatory increases in pancreatic insulin
secretion. Therefore, in order to fully as-
sess and understand the progression to
diabetes, the degree of insulin resistance
should be interpreted relative to insulin
secretion.
The relationship between insulin re-
sistance and insulin secretion is hyper-
bolic and is sometimes referred to as the
hyperbolic law of glucose tolerance (1–
3,4). This relationship is represented by
the disposition index (DI), the product of
the insulin sensitivity index (Si) and acute
insulin response to intravenous glucose
(AIRg), both of which are modeled as pa-
rameters in the intravenous glucose toler-
ance test through the minimal model of
Bergman (5). DI physiologically repre-
sents the degree to which the pancreatic
-cells are able to fully or partially com-
pensate for changes in insulin sensitivity
and is an accepted measure of pancreatic
-cell function. In normal individuals, DI
is relatively high; however, in those along
the progression from normal to type 2 di-
abetes, DI becomes progressively lower,
reﬂecting a decreased ability of the pan-
creas to fully compensate for increases in
insulin resistance (6–10).
The beneﬁcial effect of exercise on in-
sulin sensitivity is well known. However,
theeffectsofexerciseonAIRgandDIhave
not been well studied. We are not aware
of any studies that have investigated the
effects of different amounts or intensities
of exercise on AIRg or DI. The purpose of
Studies of a Targeted Risk Reduction In-
tervention through Deﬁned Exercise
(STRRIDE), a large, randomized, con-
trolled clinical trial, was to investigate the
effects of different amounts and intensi-
ties of exercise training on numerous car-
diometabolic risk factors. This report
focuses on the STRRIDE ﬁndings perti-
nent to -cell function.
RESEARCH DESIGN AND
METHODS— These data are part of
the STRRIDE project described in detail
previously (11,12). Subjects were aged
40–65 years, sedentary, overweight, or
mildly obese (BMI 25–35 kg/m
2) and
moderately dyslipidemic (either LDL
cholesterol 130–190 mg/dl and/or HDL
cholesterol 40 mg/dl for men or 45
mg/dl for women). Women were post-
menopausal. Exclusion criteria included
medications that alter carbohydrate me-
tabolism, diabetes, inability to exercise,
and history of hypertension or heart dis-
ease. The protocol was approved by the
relevant institutional review boards, and
subjects provided written informed
consent.
Exercise training
All subjects were randomly assigned to
one of three training groups or a control
group. The exercise groups were 1)
high amount/vigorous intensity, 2)
low amount/vigorous intensity, and 3)
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high-amount/vigorous-intensity group
prescription was to expend 23 kcal   kg
body wt
1   week
1 exercising at 65–
80% peak VO2 (approximately calorically
equivalent to 20 miles per week of
walking or jogging). For the low-amount/
vigorous-intensity group, the prescrip-
tion was to expend 14 kcal   kg body
wt
1   week
1 (approximately calorically
equivalent to 12 miles per week). For the
low-amount/moderate-intensity group,
subjects were to expend 14 kcal   kg body
wt
1   week
1 at 40–55% peak VO2 (Ta-
ble 1). Exercise modes included treadmill
and elliptical trainers. All exercise ses-
sions were veriﬁed by direct supervision
or recordable heart rate monitors.
Crossover control subjects
Participantswereassuredthatiftheywere
assigned to the control group, after this
period, they would be randomized into
one of the exercise groups. This was im-
portant for recruiting subjects to an exer-
cisestudy.Subjectswhobothﬁnishedthe
controlperiodandthenwererandomized
to and ﬁnished one of the exercise inter-
ventions had data for both control
changes and exercise changes. To main-
taintheindependentrelationbetweenthe
control changes and the exercise inter-
vention changes, we have not used both
control and exercise data from the same
subject when comparing exercise re-
sponse to control subjects. However,
whenexercise-onlyquestionswereofpri-
mary interest, as in the present study, we
have used the exercise change data but
not the control data from these subjects.
This approach increases the statistical
power for comparisons between exercise
interventions because it increases the
number of subjects in each of the exer-
cise groups. All data from subjects that
completed exercise training are in-
cluded in these analyses; the control
data are included only for nonstatistical
comparisons.
Insulin action measures
Insulin action was determined with a 3-h
intravenous glucose tolerance test (5).
Glucose (50%) was injected through a
catheter at 0.3 g/kg body mass. Insulin
(0.025 units/kg body mass) was injected
at min 20. Twenty-six blood samples
were obtained, centrifuged, and stored at
80°C. Insulin was measured by immu-
noassay (Access Immunoassay System;
BeckmanCoulter,Fullerton,CA)andglu-
cose with an oxidation reaction (YSI
2300; Yellow Springs, OH). Si, AIRg, and
DI were calculated using Bergman’s min-
imal model (5).
Statistical methods
Baseline differences between the exercise
groups were evaluated via ANOVA with
Fisher’s post hoc test. Pre- to posttraining
changes were determined independently
for each of the four groups by two-tailed t
tests. To determine differential training
effects between the exercise-only groups
for DI, Si, or AIRg, ANOVA with Fisher’s
post hoc tests were used. P values 0.05
for individual t tests and for post hoc tests
were considered statistically signiﬁcant.
RESULTS— Of 387 subjects random-
ized in STRRIDE, 260 completed the
study and 127 (32.8%) dropped out. Of
260, 237 had complete pre- and postint-
ervention data for the glucose tolerance
test. Table 1 describes the exercise inter-
ventions in detail.
The results for DI, AIRg, and Si are
presented in Table 2 and also in Fig. 1. In
Table 2, the data show that DI was signif-
icantly improved for the low-amount/
moderate-intensity and for the high-
amount/vigorous-intensity groups. The
low-amount/vigorous-intensity group
was on the border of signiﬁcance (P 
0.063). Surprisingly, the improvement
in DI that occurred in the moderate-
intensity group was signiﬁcantly greater
than in both of the vigorous-intensity
groups (Fig. 1). All three groups experi-
encedsigniﬁcantimprovementsinSi.The
magnitude of the improvement for the
moderate-intensity group was signiﬁ-
cantly greater than that for the same
amountofexerciseatavigorousintensity,
indicating a clear beneﬁcial effect of mod-
erate intensity over vigorous intensity for
Si. Interestingly, only the high-amount/
vigorous-intensity group showed the ex-
pected compensatory decrease in insulin
response to the glucose challenge (AIRg
decreased by 15.2% in this group). There
was virtually no compensatory decrease
in AIRg in the group that had the greatest
improvement in Si (i.e., the moderate-
intensity group; AIRg decreased only
2.2%).Whensexwasaddedtothemodel,
there were no signiﬁcant sex differences
or sex by group interactions for DI, AIRg,
or Si.
The inactive control group experi-
enced a signiﬁcant increase in fasting glu-
cose, indicating a progression toward
diabetes (Table 2). We observed signi-
ﬁcant deterioration in several other
variables including fasting insulin, ho-
meostasis model assessment, body mass,
Table 1—Exercise prescription adherence by group and substrate use
Low amount/
moderate
intensity
Low amount/
vigorous
intensity
High amount/
vigorous
intensity
n 57 58 64
Prescription and actual exercise dose
Intensity (% peak oxygen
consumption) 40–55% 65–80% 65–80%
Prescription amount
(miles/week)* 12 12 20
Prescription amount (kcal/week) 1,220  212 1,230  177 2,020  307
Prescription time (min/week) 201  37 125  28 207  44
Adherence (%) 88  14 90  12 84  15
Actual amount (miles/week)† 10.6 10.8 16.8
Actual time (min/week)‡ 176  36 113  28 172  41
Frequency (sessions/week) 3.5  0.8 2.9  0.5 3.6  0.8
Respiratory exchange ratio 0.907  0.05§ 0.960  0.06 0.961  0.04
Fat utilization
Energy from fat (%) 30.2% 12.6% 12.6%
kcals from fat (kcal) 368 155 255
Data are means SD. *Prescription amount is presented as the approximate number of miles/week that are
caloricallyequivalenttotheprescribedkcal/weekof14kcal kgbodywt
1 week
1forthelow-dosegroups
and 23 kcal   kg body wt
1   week
1 for the high-dose group. †Actual amount  prescription amount 
adherenceforeachgroup(thereforenoSD).‡Actualtimeprescriptiontimeadherenceforeachsubject.
Respiratory exchange ratios were obtained during the submaximal exercise bout that was performed to
determine the correct exercise intensity (i.e., 40–55% for the moderate-intensity group and 65–80% for the
vigorous-intensity groups). §Respiratory exchange ratio for the moderate-intensity group was signiﬁcantly
different from both vigorous groups (P  0.0005).
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the inactive control group. All exercise
groups experienced signiﬁcantly reduced
triglycerides, but the low-amount/
moderate-intensitygrouphadthegreatest
decrease, signiﬁcantly greater than the
same amount of vigorous exercise (P 
0.035) and trending toward a greater de-
crease than even the high-amount group
(P  0.085). The moderate-intensity
group had the greatest decrease in fasting
insulin; however, this difference was not
signiﬁcant (P  0.19). Only the high
amount of exercise was sufﬁcient to re-
duce visceral fat. All exercise programs
resulted in signiﬁcant improvements in
peak oxygen consumption.
Alldatawereinvestigatedforoutliers.
We identiﬁed two outliers for DI change
(4 SDs above the mean). Removal of
these two individuals had no effect on the
signiﬁcance of any analyses or on the in-
terpretation of any of the ﬁndings, and as
a result they were retained in all analyses.
CONCLUSIONS — The DI (DI 
AIRgSi)isanacceptedmeasureofpan-
creatic -cell function and predicts the
development of type 2 diabetes (13). The
major ﬁnding of the present study was
that moderate-intensity exercise training
improved DI signiﬁcantly better than did
vigorous-intensity exercise in sedentary,
overweight, moderately dyslipidemic
subjects. It is important to note that all
three exercise-training regimens resulted
in improved DI, although the low-
amount/vigorous-intensity group was
just on the border of statistical signiﬁ-
cance (P  0.063). Although DI has been
showntopredictthedevelopmentoftype
2 diabetes (13), additional studies would
be necessary to determine whether the
greater effect of moderate-intensity exer-
cise on DI actually translated into a
greater reduction in diabetes risk.
Asecondobservationrelatedtotheear-
ly-phase pancreatic -cell responses to the
intravenous glucose challenge. While mod-
erate intensity exercise resulted in the larg-
est improvement in Si, this group
experienced almost no compensatory de-
crease in ﬁrst-phase insulin secretion (AIRg
decreased 2%, nonsigniﬁcant); together,
these effects resulted in a larger improve-
ment in DI in this group versus the others.
High-amount/vigorous-intensity exercise
resultedinasimilarincreaseinSi;however,
this group did have a compensatory de-
crease in insulin secretion (AIRg decreased
15%,P0.007);together,thisresultedina
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versus the moderate-intensity group.
It is not altogether clear which of these
is a preferable response for metabolic
health. The subjects in this trial had DI lev-
els that were well below those observed in
healthyindividuals(ouraveragebaselineDI
was 1,400 compared with other reports
for normal individuals ranging from 2,000
to2,800)(6,8,9).Also,inoverweight/obese
subjects, AIRg decreases progressively
acrosslevelsofglucosetolerance(fromnor-
maltoimpairedtodiabetic)(8,9).Ourown
baseline data show a clear and progressive
decrease in AIRg (and also DI and Si) even
acrosstertilesofnormalglucose(100mg/
dl;datanotshown).Therefore,theresponse
experienced by the moderate-intensity in-
tervention might reﬂect a transition toward
a more normal and perhaps healthier DI.
On the other hand, consistent ﬁndings of
exercise-induced reductions in insulin lev-
els (area under the curve) in response to an
oral glucose challenge (14), and decreased
insulin secretion with hyperglycemic
clamps (15), have been a hallmark ﬁnding
in exercise research, although the majority
of these studies have been in response to
vigorous exercise only.
The speciﬁc mechanisms responsible
for these observations are not obvious. In
previous publications in this study cohort,
we have observed that the high-amount
group, compared with both low-amount
exercisegroups,experiencedgreaterreduc-
tions in body weight, body fat, waist cir-
cumference (16), visceral and abdominal
subcutaneous fat (17), and greater and
more widespread improvements in lipids
and lipoproteins (11), as well as greater im-
provements in cardiovascular ﬁtness (18).
With the exception of ﬁtness, exercise in-
tensitywasnotafactorcontributingtothese
differences; rather, the effect was due to a
greater amount of exercise. Therefore, it
seems clear, at least in the present study,
that the greater improvement in DI result-
ing from moderate-intensity exercise can-
not be explained by the factors more
favorably modulated by vigorous exercise.
In contrast, we have also previously re-
ported that the moderate-intensity group
experienced a number of unexpected met-
abolic beneﬁts including 1) a greater reduc-
tion in plasma triglycerides (both acute and
chronic), compared with both vigorous-
intensity groups (11,19); 2) a greater increase
in insulin sensitivity at both 24 h after the last
bout and after 14 days after exercise with-
drawal(20,21),whichissigniﬁcantlydifferent
from the same amount of vigorous exercise;
and 3) a greater improvement in metabolic
syndrome score compared with the same
amount of vigorous exercise training (22).
It is well known that expending the
same number of calories while exercising at
a moderate intensity compared with vigor-
ous intensity results in a lower respiratory
exchangeratio,theratioofCO2production
to O2 consumption (23,24), and thus re-
ﬂects a greater percentage of fat oxidation
for energy when compared with more vig-
orous exercise. Recently, in a study designed
to investigate exercise training at an intensity
that optimizes fat oxidation (FATmax), Ven-
ables and Jeukendrup (24) reported that
moderate-intensity training improved both Si
andfatoxidationmorethanthesameamount
of interval exercise training.
The robust effects observed with
moderate-intensityexerciseinthesestud-
ies may be the result of improved fat
oxidation leading to a reduction in lipo-
toxicity in skeletal muscle, liver, and/or
pancreas. Schenk and Horowitz (25) re-
cently observed that acute exercise in-
creases triglyceride synthesis in skeletal
muscle and prevents fatty acid–induced
insulin resistance. Although they only
studiedoneexerciseintensity(moderate),
they reported numerous responses in
skeletal muscle that likely explain the
acute effects, including enhanced key li-
pogenic enzymes, an increase in muscle
triglyceride synthesis, reduced partition-
ing of fatty acids toward ceramide and di-
acylglycerol (both hypothesized to be
causallyrelatedtoinsulinresistance),and
Figure1—TheeffectsofexerciseamountandintensityonchangesinDI(A),Si(B),andAIRg(C)
areshown.DataaremeansSE.AllPvalues0.10forgroupcomparisonsarereported.Forlow
amount/moderate intensity (n  57); low amount/vigorous intensity (n  58); high amount/
vigorous intensity (n  64).
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sponse. It seems likely that moderate-
intensity exercise, which relies more
heavily on fat oxidation, may be more ef-
fective than vigorous exercise in creating
these speciﬁc adaptations. Our observa-
tion of greater acute and chronic reduc-
tions in plasma triglycerides with
moderate compared with vigorous exer-
cise (19) supports this hypothesis.
Finally, another important ﬁnding of
the present study was the clinically and
statisticallysigniﬁcantincreaseofnearly3
mg/dl in fasting glucose that occurred in
the control group. There were no signiﬁ-
cant changes in fasting glucose in any ex-
ercise group emphasizing the important
preventive effects of regular exercise on
the deterioration of glucose control that
occurs with physical inactivity, positive
energy balance, and weight gain.
In summary, 8 months of continued
physical inactivity in sedentary overweight
and obese individuals with moderate dys-
lipidemialedtoasigniﬁcantincreaseinfast-
ing glucose levels, indicating a progression
toward type 2 diabetes. Further, to the ex-
tent that the DI accurately reﬂects -cell
function, we observed that both moderate-
and vigorous-intensity exercise improved
-cell function but through distinct mech-
anisms. The high amount of vigorous-
intensity exercise was associated with an
improvement in insulin sensitivity and a
compensatorydecreaseininsulinsecretion.
The low amount of moderate-intensity ex-
ercise was associated with a similar im-
provement in insulin sensitivity but with
almost no reduction in insulin secretion.
While the moderate-intensity intervention
might reﬂect a transition toward a more
normal DI in sedentary, moderately dyslip-
idemic individuals, longer-term investiga-
tions would be necessary to conﬁrm a
superior improvement in diabetes risk.
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